As the utility of oral iron is limited due to short wait times (29 days) until surgery, and the use of erythropoietin stimulating agents is discouraged due to thrombosis and malignancy concerns, IV iron is often the only choice for the treatment of pre-operative anemia in HPB patients [20]. The gene discussed is EPO; the disease is anemia.